Article Information
History
- October 21, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Peter J. Embi1,2,*,
- Matthew E. Levy3,#,
- Palak Patel4,
- Malini B. DeSilva5,
- Manjusha Gaglani6,
- Kristin Dascomb7,
- Margaret M. Dunne3,
- Nicola P. Klein8,
- Toan C. Ong9,
- Shaun J. Grannis2,10,
- Karthik Natarajan11,12,
- Duck-Hye Yang3,
- Edward Stenehjem7,
- Ousseny Zerbo8,
- Charlene McEvoy5,
- Suchitra Rao9,
- Mark G. Thompson4,
- Deepika Konatham6,
- Stephanie A. Irving13,
- Brian E. Dixon2,14,
- Jungmi Han11,
- Kristin E. Schrader3,
- Nancy Grisel7,
- Ned Lewis8,
- Anupam B. Kharbanda15,
- Michelle A. Barron9,
- Sue Reynolds4,
- I-Chia Liao6,
- William F. Fadel2,14,
- Elizabeth A. Rowley3,
- Julie Arndorfer7,
- Kristin Goddard8,
- Kempapura Murthy6,
- Nimish R. Valvi2,
- Zachary A. Weber3,
- Bruce Fireman8,
- Sarah E. Reese3,
- Sarah W. Ball3 and
- Allison L. Naleway13
- 1Vanderbilt University Medical Center, Nashville, Tennessee, USA
- 2Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana, USA
- 3Westat, Rockville, Maryland, USA
- 4Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta, Georgia, USA
- 5HealthPartners Institute, Minneapolis, Minnesota, USA
- 6Baylor Scott & White Health, Texas A&M College of Medicine, Temple, Texas, USA
- 7Division of Infectious Diseases and Clinical Epidemiology, Intermountain Healthcare, Salt Lake City, Utah, USA
- 8Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California Division of Research, Oakland, California, USA
- 9School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA
- 10Indiana University School of Medicine, Indianapolis, Indiana, USA
- 11Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, New York, USA
- 12New York Presbyterian Hospital, New York, New York, USA
- 13Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA
- 14Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana, USA
- 15Children’s Minnesota, Minneapolis, MN, USA
- ↵*Corresponding author:
Peter J. Embi, MD, MS, FACP, FACMI, FIAHSI, Vanderbilt University Medical Center, 2525 West End Avenue, Suite 1475, Nashville, TN 37203, email: peter.embi{at}vumc.org,phone: 615-936-6867, fax: 615-936-010 - ↵#Alternate corresponding author:
Matthew E. Levy, PhD, Public Health & Epidemiology Practice, Westat, 1600 Research Blvd, Rockville, MD 20850, email: matthewlevy{at}westat.com,phone: 301-251-1500, fax: 301-610-4820
Posted October 21, 2022.
Effectiveness of COVID-19 Vaccines at Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompromised Adults: An Observational Study of Real-World Data Across 10 US States from August-December 2021
